Company Overview
AbMax Biotechnology Co., Ltd. was established in 2006 and now is a high-tech enterprise and training base for the national life science and technical personnel.

AbMax Biotechnology Co., LTD was incorporated in Beijing, China, in 2006. AbMax has 1200 m2 research facility and 300 m2 office space.

AbMax has the world’s most advanced one-stop technology platform for antibodies and kits researching, which has the monoclonal antibody developed in an average of 46 days with a high success rate of 90%.